Paxlovid - dmd



Coding system
Dictionary of Medicines and Devices
Coding system release
2024 6.1.0
Organisation
OpenSAFELY
Codelist ID
opensafely/paxlovid-dmd
Version ID
6b7e2962

Versions
  • 6b7e2962

Description

A codelist to identify all prescribing of Paxlovid (Nirmatrelvir with Ritonavir).

User requirements Codelist needed to return all recorded prescriptions of Paxlovid in primary care records. This will be used to plot the recorded prescribing in primary care of all COVID-19 therapeutics.

Sensitivity versus specificity Volumes expected to be low, and drugs specific, so sensitivity to be prioritised

Relevant definitions or links to important reference sources N/A

Coding system dm+d

Existing relevant codelists https://github.com/opensafely/Paxlovid-and-sotrovimab/blob/main/codelists/bangzheng-paxlovid-dmd-0964dee3.csv

Methodology

Converted from pseudo-BNF system codelist

References

Signed off by

  • Chris Wood, (June 17, 2024)
  • Vicky Speed, (June 17, 2024)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.

dmd_type dmd_id dmd_name bnf_code
VMP 40326811000001109 Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets 0503060B0AAAAAA
AMP 40325011000001107 Paxlovid 150mg/100mg tablets 0503060B0BBAAAA

* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.